These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 8425437

  • 1. Prospective study of efficacy and safety of lansoprazole in Zollinger-Ellison syndrome.
    Metz DC, Pisegna JR, Ringham GL, Feigenbaum K, Koviack PD, Maton PN, Gardner JD, Jensen RT.
    Dig Dis Sci; 1993 Feb; 38(2):245-56. PubMed ID: 8425437
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Long-term lansoprazole control of gastric acid and pepsin secretion in ZE and non-ZE hypersecretors: a prospective 10-year study.
    Hirschowitz BI, Simmons J, Mohnen J.
    Aliment Pharmacol Ther; 2001 Nov; 15(11):1795-806. PubMed ID: 11683694
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Long-term treatment with lansoprazole for patients with Zollinger-Ellison syndrome.
    Hirschowitz BI, Mohnen J, Shaw S.
    Aliment Pharmacol Ther; 1996 Aug; 10(4):507-22. PubMed ID: 8853754
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A prospective study of the effectiveness of low dose omeprazole as initial therapy in Zollinger-Ellison syndrome.
    Termanini B, Gibril F, Stewart CA, Weber HC, Jensen RT.
    Aliment Pharmacol Ther; 1996 Feb; 10(1):61-71. PubMed ID: 8871445
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Maintenance oral pantoprazole therapy is effective for patients with Zollinger-Ellison syndrome and idiopathic hypersecretion.
    Metz DC, Soffer E, Forsmark CE, Cryer B, Chey W, Bochenek W, Pisegna JR.
    Am J Gastroenterol; 2003 Feb; 98(2):301-7. PubMed ID: 12591045
    [Abstract] [Full Text] [Related]

  • 11. Clinical outcome using lansoprazole in acid hypersecretors with and without Zollinger-Ellison syndrome: a 13-year prospective study.
    Hirschowitz BI, Simmons J, Mohnen J.
    Clin Gastroenterol Hepatol; 2005 Jan; 3(1):39-48. PubMed ID: 15645403
    [Abstract] [Full Text] [Related]

  • 12. Helicobacter pylori effects on gastritis, gastrin and enterochromaffin-like cells in Zollinger-Ellison syndrome and non-Zollinger-Ellison syndrome acid hypersecretors treated long-term with lansoprazole.
    Hirschowitz BI, Haber MM.
    Aliment Pharmacol Ther; 2001 Jan; 15(1):87-103. PubMed ID: 11136282
    [Abstract] [Full Text] [Related]

  • 13. [Comparative efficacy of lansoprazole and omeprazole on the intragastric pH measured over a period of 24 hours and on the basal].
    Paul G, Ramdani A, Mignon M, Vallot T, Forestier S, Cadiot G, Ruszniewski P, Joubert-Collin M.
    Gastroenterol Clin Biol; 1994 Jan; 18(8-9):695-701. PubMed ID: 7875436
    [Abstract] [Full Text] [Related]

  • 14. Minor effects of Helicobacter pylori on gastric secretion and dose of lansoprazole during long-term treatment in ZE and non-ZE acid hypersecretors.
    Hirschowitz BI, Simmons J, Mohnen J.
    Aliment Pharmacol Ther; 2002 Feb; 16(2):303-13. PubMed ID: 11860414
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Use of omeprazole in Zollinger-Ellison syndrome: a prospective nine-year study of efficacy and safety.
    Metz DC, Strader DB, Orbuch M, Koviack PD, Feigenbaum KM, Jensen RT.
    Aliment Pharmacol Ther; 1993 Dec; 7(6):597-610. PubMed ID: 8161665
    [Abstract] [Full Text] [Related]

  • 17. Presentation, response to lansoprazole therapy, and outcome of Zollinger-Ellison syndrome-like gastric acid hypersecretors.
    Wilcox CM, Seay T, Arcury J, Hirschowitz BI.
    Scand J Gastroenterol; 2011 Mar; 46(3):277-80. PubMed ID: 21073392
    [Abstract] [Full Text] [Related]

  • 18. [Lansoprazole--profile of a new proton pump inhibitor].
    Seifert E.
    Leber Magen Darm; 1994 Mar; 24(2):66-8, 71. PubMed ID: 8196467
    [Abstract] [Full Text] [Related]

  • 19. Intravenous pantoprazole rapidly controls gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
    Lew EA, Pisegna JR, Starr JA, Soffer EF, Forsmark C, Modlin IM, Walsh JH, Beg M, Bochenek W, Metz DC.
    Gastroenterology; 2000 Apr; 118(4):696-704. PubMed ID: 10734021
    [Abstract] [Full Text] [Related]

  • 20. An open-label study of rabeprazole in patients with Zollinger-Ellison syndrome or idiopathic gastric acid hypersecretion.
    Morocutti A, Merrouche M, Bjaaland T, Humphries T, Mignon M.
    Aliment Pharmacol Ther; 2006 Nov 15; 24(10):1439-44. PubMed ID: 17081164
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.